نتائج البحث 351-360 من 23343 لعملية البحث عن B cell lymphomas
Axicabtagene Ciloleucel versus Standard of Care Therapy as First-Line Therapy in High-Risk Large B-Cell Lymphoma. Rochester, Minn., La Crosse, Wis., Mankato ...
... B-cell Lymphoma (R/R DLBCL). Rochester, Minn. Study B9991011 is a multi-center, international, randomized, open label, 2 component (Phase 1b followed by ...
Primary CNS lymphoma treatment (PDQ) — Patient version https://www.cancer.gov/types/lymphoma/patient/primary-cns-lymphoma-treatment-pdq. ... B-cell lymphoma.
... B-cell lymphoma 2 (BCL2) inhibitor. A Study to Evaluate Immune and Hematopoietic Cell Assessment in Clonal B Cell Conditions. Rochester, Minn. The purpose of ...
Jacksonville, Fla. The purposes of this study are to explore the therapeutic efficacy of BAFFR-CAR T cells in BAFFR-expressing B-cell hematologic malignancies ...
Safety/Efficacy of MEDI-551 in Combination With Immunomodulating Therapies in Subjects With Aggressive B-cell Lymphomas. Rochester, Minn. This is a Phase 1b ...
... b-cell lymphoma (DLBCL) patients with out of specification leukapheresis product and/or manufactured tisagenlecleucel out of specification for commercial ...
... cell lymphoma, Lymphoma, B-cell lymphoma, Diffuse large b-cell lymphoma, T-cell lymphoma, Follicular lymphoma, Cutaneous b-cell lymphoma. إظهار المزيد من ...
Treatment of relapsed or refractory mantle cell lymphoma. https://www.uptodate.com/contents/search. Accessed May 2, 2025. B-cell lymphomas. National ...
لا تُقدم Mayo Clinic الدعم للشركات أو المنتجات المُعلَّن عنها هنا. لكن تدعم العائدات الإعلانية رسالتنا غير الربحية.
تحقق من هذه الكتب الأكثر مبيعًا والعروض الخاصة على الكتب والنشرات الإخبارية من Mayo Clinic Press.
تساهم التبرّعات، وهي قابلة للخصم الضريبي، في دعم آخر التطورات في الأبحاث وطرق الرعاية لإحداث نقلة نوعية في الطب.